公司資料

Ocugen 股價、新聞與催化劑

股票代碼:: OCGN
交易所:: NASDAQ
產業:: Biopharma
所在地:: United States

股票表現

1.03 USD (+3.17%)

收盤價

最後更新: 2026年9月17日

454M USD

市值

股價為何變動

截至 2026年9月17日，OCGN 上漲 3.17%，收於 $1.03。目前新聞監測窗口內未發現新的同公司新聞。

公司概覽

業務概覽

Ocugen is a biotechnology company focused on ophthalmology, gene therapy, and vaccine-related programs. Its story has been shaped by a mix of platform ambition and strategic pivots.

所在地與產業分類

Headquartered in the United States and listed on NASDAQ, Ocugen sits in specialty biotechnology.

商業模式特徵

The company depends on clinical development, partnership progress, and the ability to create value across a narrow set of programs.

生技產業定位

Ocugen is a high-uncertainty biotech name whose valuation is driven by strategy and development milestones.

未來催化劑

Ocugen’s catalysts are the gene-therapy and biologics pipeline, with any update on retinal or vaccine-related work shaping the next leg. The market will want a clearer human-data path before assigning more value.